Researchers engineered microalgae-powered microbots designed to deliver chemotherapy directly into bladder tumors with guidance from magnetic fields and monitoring via real-time imaging. The report describes improved drug penetration into tumor tissue while aiming to spare surrounding healthy cells. The approach positions biohybrid microrobots as a delivery platform for localized oncology, potentially addressing a key limitation of conventional chemotherapy delivery—insufficient distribution throughout tumor masses. In bladder cancer, where the tumor microenvironment can limit exposure, direct intratumoral precision is a central development goal. While the report does not provide trial or regulatory context, the study’s emphasis on steering and imaging control suggests a translational pathway centered on controllable biodelivery and measurable distribution outcomes.